Description

At GLP1 Peptides, we support major research facilities by providing high-capacity compounds. Retatrutide 60mg represents a significant milestone in peptide synthesis, acting as a unimolecular triple agonist designed for investigators requiring higher concentrations for extensive longitudinal studies.

Retatrutide is uniquely engineered to engage three critical metabolic pathways:

1. GLP-1 (Glucagon-Like Peptide-1)

2. GIP (Glucose-Dependent Insulinotropic Polypeptide)

3. GR (Glucagon Receptor)

This multi-receptor mechanism is essential for studies focused on advanced energy homeostasis, systemic metabolism, and cellular signaling pathways.

The GLP1 Peptides Quality Standard

• 99% Purity Guaranteed: Every batch of Retatrutide 60mg is verified through HPLC and Mass Spectrometry to ensure a purity rating of 99% or higher.

• Advanced Lyophilization: Our professional freeze-drying process protects the delicate molecular structure of the peptide, ensuring long-term stability and shelf life in a laboratory setting.

• Analytical Transparency: Every shipment is accompanied by a batch-specific Certificate of Analysis (COA), providing the data integrity required for high-level scientific experimentation.

• Precision Synthesis: Our laboratory protocols prioritize exact amino acid sequencing to provide a consistent and reliable research tool for complex studies.

Technical Product Specifications:

• Compound Name: Retatrutide

• Vial Concentration: 60mg Single Compound

• Format: White Lyophilized Powder

• Target Receptors: GIP, GLP-1, and Glucagon Receptors

• Purity Rating: >99%

• Storage Requirements: Store at -20°C for optimal long-term stability and potency.